Company Filing History:
Years Active: 2025
Title: Bart Ecg De Goeij: Innovator in Antibody Development
Introduction
Bart Ecg De Goeij is a notable inventor based in Maarssen, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of multispecific antibodies. His work focuses on therapeutic applications, especially in cancer treatment.
Latest Patents
Bart Ecg De Goeij holds a patent for "Antibodies binding to fibroblast activation protein alpha and death receptor 4." This invention relates to a multispecific antibody that includes a FAPα binding region and a DR4 binding region. The patent outlines the pharmaceutical compositions that comprise these antibodies and their use in therapeutic and diagnostic procedures, particularly in cancer therapy. He has 1 patent to his name.
Career Highlights
Bart is associated with Genmab AS, a leading biotechnology company known for its innovative cancer therapies. His role at Genmab has allowed him to contribute to groundbreaking research and development in the field of antibody-based treatments.
Collaborations
He has collaborated with talented coworkers such as Ilse Jongerius and Grietje Andringa, enhancing the research environment and fostering innovation within the company.
Conclusion
Bart Ecg De Goeij is a prominent figure in the biotechnology sector, with a focus on developing innovative antibody therapies. His contributions are paving the way for advancements in cancer treatment and diagnostics.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.